Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Holding DGX?
Track your performance easily
DGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$119.59 - $159.36
Previous Close$155.48
Volume519.54K
Average Volume (3M)838.52K
Market Cap
$17.31B
Enterprise Value$22.24B
Total Cash (Recent Filing)$271.00M
Total Debt (Recent Filing)$5.09B
Price to Earnings (P/E)21.0
Beta0.46
Next Earnings
Oct 22, 2024EPS Estimate
$2.28Next Dividend Ex-Date
Oct 04, 2024Dividend Yield1.88%
Share Statistics
EPS (TTM)7.41
Shares Outstanding111,317,208
10 Day Avg. Volume697,777
30 Day Avg. Volume838,518
Standard Deviation0.09
R-Squared0.27
Alpha0.00163
Financial Highlights & Ratios
Price to Book (P/B)2.62
Price to Sales (P/S)1.85
Price to Cash Flow (P/CF)12.00
P/FCF Ratio14.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.38
Enterprise Value/Gross Profit7.29
Enterprise Value/Ebitda16.59
Forecast
1Y Price Target
$154.70Price Target Upside-0.27% Downside
Rating ConsensusHold
Number of Analyst Covering12
Quest Diagnostics News
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe LifeLabs acquisition is expected to provide modest accretion to Quest Diagnostics' financial performance.
Financial PerformanceQuest Diagnostics reported broadly solid 2Q24 results, with sales and adjusted EPS both coming in modestly ahead.
Revenue GrowthBase business trends remain stable, benefiting from broad-based elevated utilization as well as solid growth in the physician and hospital markets.
Bears Say
EarningsShares traded off on incremental worries, namely, LifeLabs initial accretion less than many thought, newly disclosed small employer business headwinds and incremental headwinds impacting 3Q24 EPS.
Financial PerformanceLowering estimates for FY25 and beyond to account for a lower assumed margin for the LifeLabs acquisition.
RevenueThere is an expected revenue headwind from an IT outage and Hurricane Beryl in Texas in 3Q.
---
Ownership Overview
1.77% Insiders
31.71% Mutual Funds
44.75% Other Institutional Investors
21.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $119.59 and its highest was $159.36 in the past 12 months.
What is Quest Diagnostics’s market cap?
Currently, no data Available
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Oct 22, 2024 which is in 32 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Jul 23, 2024. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.335 by $0.015.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Overvalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 1.88%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is $2.28.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,317,210 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.35 in its last earnings report, beating expectations of $2.335. Following the earnings report the stock price went down -4.337%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 327M.
---
Quest Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$154.70 (-0.27% Downside)
$154.70 (-0.27% Downside)
Blogger Sentiment
Bullish
DGX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 617.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.37%
12-Months-Change
Fundamentals
Return on Equity
13.00%
Trailing 12-Months
Asset Growth
3.40%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
---
DGX Earnings Call
Q2 2024
0:00 / 0:00
---
DGX Revenue Breakdown
97.02% Diagnostic Information Services
2.98% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$154.70
▼(-0.27% Downside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
26/38 ratings generated profit
1 Year Average Return
+7.64%
reiterated a buy rating 2 months ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +7.64% per trade.
---